Abstract
Recent discoveries on the molecular and cellular basis of asthma have markedly altered our understanding of this common respiratory disorder. These insights have come during an unexplained period of rising disease incidence and severity and are now being applied to develop improved therapies. This review explores the latest advances in our understanding of the pathogenesis of allergic asthma, and provides insight into the expanding collaborations between research scientists, clinicians and the pharmaceutical industry in the race to control the asthma epidemic.
Original language | English (US) |
---|---|
Pages (from-to) | 55-64 |
Number of pages | 10 |
Journal | Nature Reviews Drug Discovery |
Volume | 1 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2002 |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery